NIH T32 Meetings

Summer 2020 Research Meeting via Teams: June 28, 2020

NIH T32 Summer Meeting via Teams

Dr. Kytai Nguyen

Dr. Nguyen and the UTA NIH T32 fellows adapt to challenges by taking the meetings online.

Fall 2018 Research Poster Session: October 2, 2018

Aneetta Kuriakose presents her nanotechnology research progress for treatment of peripheral arterial disease.

Aneetta Kuriakose

Aneetta Kuriakose presents her nanotechnology research progress for treatment of peripheral arterial disease.

Dr. Liping Tang and Tam Nguyen listen as Duong Le, a Ph.D. candidate in Dr. Nguyen’s lab, explains his research.

Duong Le

Dr. Liping Tang and Tam Nguyen listen as Duong Le, a Ph.D. candidate in Dr. Nguyen’s lab, explains his research.

Elizabeth Lyde, a 2nd year NIH T32 Fellow, shares her research with fellow Ph.D. candidate Caleb Liebman.

Elizabeth Lyde

Elizabeth Lyde, a 2nd year NIH T32 Fellow, shares her research with fellow Ph.D. candidate Caleb Liebman.

Katherine Copeland explains her research to Alan Taylor, a 1st year NIH T32 Fellow.

Katherine Copeland

Katherine Copeland explains her research to Alan Taylor, a 1st year NIH T32 Fellow.

Summer 2018 Special Topics in Nanotechnology: May 30, 2018

Spring 2018 Update: March 6, 2018

May 2018 Summer NIH Meeting

Aneetta Kuriakose introduces her research topic and discusses her yearly progress.

Aneetta Kuriakose

Aneetta Kuriakose introduces her research topic and discusses her yearly progress. Aneetta is working to prevent the complications such as restenosis after percutaneous coronary interventions by promoting regeneration/accelerated healing of injured endothelial layer using nanotechnology.

Aneetta Kuriakose and Victoria Messerschmidt pause to discuss what they have learned at the meeting.

Discussions

Aneetta Kuriakose and Victoria Messerschmidt pause to discuss what they have learned at the meeting. NIH fellows were tasked with teaching each other about the following topics: Emerging nanotechnology landscape (Victoria M.), Nanotechnology risk and toxicology management (Katherine M.), Interactions btw engineers with hospital and companies (Aneetta K.), Entrepreneurship and intellectual property (Elizabeth L.), and Leadership development (Le’Naiya K.)

Elizabeth Lyde describes how she is working to evaluate the effects of cardiovascular risk factors on brain networks using functional Near-Infrared Spectroscopy

elizabeth lyde's presentation

Elizabeth Lyde describes how she is working to evaluate the effects of cardiovascular risk factors on brain networks using functional Near-Infrared Spectroscopy (fNIRS) and eventual integration of targeted antioxidant nanoparticles to improve systemic and brain blood flow.

Katherine Copeland explains her research progress on her idea to create a therapeutic alternative

katherine copeland's presentation

Katherine Copeland explains her research progress on her idea to create a therapeutic alternative to non-surgical patients suffering from hypertrophic obstructive cardiomyopathy using nanotechnology to the NIH mentors and other invited guests.